Help Sitemap Home Skip Navigation Contact Us Disability Statement

 
 
Friday, 5th December 2008

Premium Article !

Your account has been frozen. For your available options click the below button.

Options

Premium Article !

To read this article in full you must have registered and have a Premium Content Subscription with the The Scotsman site.

Subscribe

Registered Article !

To read this article in full you must be registered with the site.

Sign In
Register

Drug cocktail cancer hope



Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

Published Date: 13 August 2008
COMBINING a treatment for brittle bones with chemotherapy has a dramatic effect on breast cancer, new research has shown.
Scientists found the two drugs – the breast cancer chemotherapy agent doxorubicin and the bisphosphonate drug zoledronic acid – acted together to slow down tumour growth. Researchers, from the University of Sheffield and Kuopio University in Finland, wrote of their work in the Journal of the National Cancer Institute.

A clinical trial is now under way in the UK which could lead to the treatment becoming widely available.



The full article contains 89 words and appears in The Scotsman newspaper.
Page 1 of 1

  • Last Updated: 12 August 2008 10:18 PM
  • Source: The Scotsman
  • Location: Edinburgh
  • Related Topics: Cancer research
 
1

Pentland,

EDINBURGH 13/08/2008 12:19:31
Ooops! I have a problem here. An adjacent article says that doctors are trying too many pills ('pill culture') and yet, somehow, they find these 'odd' combinations of unrelated drugs that seem to work. How do they do it if not by trying them?
2

aftercancer,

Wilmington, NC 13/08/2008 13:52:44
Just a note of clarification. This is not a situation of too many pills. The drugs cited in the article above are intravenous chemotherapies. I suspect the combination of medications was found because some adjuvant hormonal treatments can cause bone loss which leads those women to take a bisphosphonate to protect their bones. In one year on Femara I went from having normal bone density to being osteopenic. Femara can remove up to 8% of bone density per year. Would I give it up? Heck no! But I then need to counter it's negative effect. www.aftercancernowwhat.wordpress.com

 

Comment on this Story

 

In order to post comments you must Register or Sign In

 
 
RSS Feed of this article's comments
Delivery formats: RSS, Atom, Javascript & Email
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.